| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015273 Stable pharmaceutical aqueous compositions |
| 01/20/2011 | US20110015271 Topical nepafenac formulations |
| 01/20/2011 | US20110015263 Therapeutic delivery of carbon monoxide |
| 01/20/2011 | US20110015248 Substituted heterocycles |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015231 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015229 Method of treating neuropathic pain |
| 01/20/2011 | US20110015228 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/20/2011 | US20110015227 Warming sensate composition |
| 01/20/2011 | US20110015220 Mixed orl1/mu-agonists for the treatment of pain |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 01/20/2011 | US20110015212 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | US20110015207 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 01/20/2011 | US20110015202 Imidazoles |
| 01/20/2011 | US20110015200 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 01/20/2011 | US20110015196 Lupeol-type triterpene derivatives as antivirals |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015188 Treatment of Seasonal Conditions |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015178 Amido-Thiophene Compounds and Their Use |
| 01/20/2011 | US20110015174 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 01/20/2011 | US20110015171 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015170 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/20/2011 | US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses |
| 01/20/2011 | US20110015138 Inhibition of inflammation using antagonists of muc1 |
| 01/20/2011 | US20110015130 Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110014308 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders. |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014285 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014280 Sequestering subunit and related compositions and methods |
| 01/20/2011 | US20110014269 Civamide patch for localized post-incisional neuropathic pain |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014205 Methods and compositions for treating chronic pelvic pain syndrome |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014158 Compositions and methods of using chondroitinase abci mutants |
| 01/20/2011 | US20110014137 Methods for protecting the skin from radiation insults |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | US20110014127 Methods for measuring a patient response upon administration of a drug and compositions thereof |
| 01/20/2011 | US20110014121 Modulators of cxcr7 |
| 01/20/2011 | US20110011392 Olopatadine nasal spray regimen for children |
| 01/20/2011 | DE102009033208A1 Aminopyridinderivate Aminopyridine |
| 01/20/2011 | CA2768460A1 Antagonists, uses & methods for partially inhibiting tnfr1 |
| 01/20/2011 | CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | CA2768236A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
| 01/20/2011 | CA2767992A1 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl] thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof |
| 01/20/2011 | CA2767971A1 Treating patients with intravenous ibuprofen |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2767833A1 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | CA2767372A1 3-phenoxymethylpyrrolidine compounds |
| 01/20/2011 | CA2766883A1 Tricyclic indole-derived spiro derivatives as crth2 modulators |
| 01/20/2011 | CA2766100A1 Pyrimidinones as pi3k inhibitors |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275140A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/19/2011 | EP2275129A2 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins |
| 01/19/2011 | EP2275113A1 Skin circulation-improving agent and skin temperature-elevating agent |
| 01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275101A1 Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2273982A2 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 01/19/2011 | EP2086540B1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 01/19/2011 | EP1902045B1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 01/19/2011 | EP1720551B1 Alkaloid formulations |
| 01/19/2011 | EP1668036B1 Method for the production of human antibodies blocking the biological activity of a human cytokine |
| 01/19/2011 | EP1608623B1 Metal ion chelators and therapeutic use thereof |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 01/19/2011 | EP1409008B1 Use of a nucleic acid molecule coding the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN201710673U Cold compress pain relieving paste |
| 01/19/2011 | CN201709412U Health and massage bra pad containing cassia seeds |
| 01/19/2011 | CN101952318A Anti-NR10 antibody, and use thereof |
| 01/19/2011 | CN101952296A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952295A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952294A Pyrrolopyrazine kinase inhibitors |
| 01/19/2011 | CN101952285A Amino triazoles as PI3K inhibitors |
| 01/19/2011 | CN101952283A Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 01/19/2011 | CN101952256A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| 01/19/2011 | CN101951908A Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948470A Application of phenanthroindolizidine alkaloid organic acid salt derivative in medicine |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948430A Sinomenine derivative and preparation method and applications thereof |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101947368A Flame-retardant body strengthening safety clothing of nano-element fiber fabric |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |